Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Phospholipase D signaling pathway	6/148	1.1139169945089601E-4	0.017154321715437987	0	0	8.695422535211268	79.14971619698557	KITLG;CYTH4;EGF;FYN;F2;HRAS
Pathogenic Escherichia coli infection	5/197	0.0033932000077379265	0.19233663212907584	0	0	5.290485395189004	30.081603922832603	CYTH4;FYN;ARHGEF2;EZR;F2
Platelet activation	4/124	0.0037468175090079707	0.19233663212907584	0	0	6.727210884353742	37.58390779345558	FYN;GP6;F2;GP5
RNA degradation	3/79	0.007694140081536769	0.20937867937896235	0	0	7.9035087719298245	38.46871875148528	EDC4;CNOT1;EXOSC1
Folate biosynthesis	2/26	0.007728760552028428	0.20937867937896235	0	0	16.561666666666667	80.53618481890834	DHFR;ALPL
Collecting duct acid secretion	2/27	0.00831949464007076	0.20937867937896235	0	0	15.8984	76.13988223925524	ATP4B;CLCNKB
JAK-STAT signaling pathway	4/162	0.009537357260287926	0.20937867937896235	0	0	5.099457504520796	23.72542414676911	CSH2;EGF;CSH1;HRAS
Galactose metabolism	2/31	0.01087681451319285	0.20937867937896235	0	0	13.702758620689655	61.95184159900207	GALE;GCK
Hematopoietic cell lineage	3/99	0.014186571816655488	0.21505593733011874	0	0	6.250631313131313	26.599307830499722	KITLG;ANPEP;GP5
Mucin type O-glycan biosynthesis	2/36	0.014495247518160977	0.21505593733011874	0	0	11.684705882352942	49.472278664136425	GALNT1;GCNT4
Pancreatic secretion	3/102	0.015361138380722767	0.21505593733011874	0	0	6.060299969390878	25.30729415703534	CPA2;CELA3B;CLCA2
Cytokine-cytokine receptor interaction	5/295	0.017622656561856475	0.2198501501285412	0	0	3.4852470671880553	14.075413900143337	CSH2;IL26;CSH1;IL31RA;AMH
Bladder cancer	2/41	0.018558778906954777	0.2198501501285412	0	0	10.184102564102565	40.60210582978711	EGF;HRAS
Growth hormone synthesis, secretion and action	3/119	0.02303066181461231	0.22158425767487538	0	0	5.167711598746082	19.487072645071017	CSH2;CSH1;HRAS
Amino sugar and nucleotide sugar metabolism	2/48	0.024949348712210842	0.22158425767487538	0	0	8.631304347826086	31.85734647733977	GALE;GCK
Neomycin, kanamycin and gentamicin biosynthesis	1/5	0.02524355128901587	0.22158425767487538	0	0	49.242574257425744	181.17251842856115	GCK
Regulation of actin cytoskeleton	4/218	0.02548608738678424	0.22158425767487538	0	0	3.7543391188251003	13.777007559802703	EGF;EZR;F2;HRAS
Cysteine and methionine metabolism	2/50	0.02691772640191098	0.22158425767487538	0	0	8.270833333333334	29.898816321570965	GOT1;BHMT2
Purine metabolism	3/129	0.02835149858173841	0.22158425767487538	0	0	4.755170755170755	16.943031893849575	GDA;IMPDH2;ENTPD6
Natural killer cell mediated cytotoxicity	3/131	0.02948749193176837	0.22158425767487538	0	0	4.6803977272727275	16.49273453183364	ICAM2;FYN;HRAS
Phenylalanine, tyrosine and tryptophan biosynthesis	1/6	0.03021603513748301	0.22158425767487538	0	0	39.392079207920794	137.84795382798865	GOT1
PI3K-Akt signaling pathway	5/354	0.03497527104426185	0.23202838714484011	0	0	2.8873364251321894	9.681568215239027	KITLG;CSH2;EGF;CSH1;HRAS
Endometrial cancer	2/58	0.035383994750707484	0.23202838714484011	0	0	7.086428571428572	23.679270506020032	EGF;HRAS
Apoptosis	3/142	0.03616026812646859	0.23202838714484011	0	0	4.307608458687596	14.300374130479732	BCL2A1;CASP10;HRAS
Cell adhesion molecules	3/148	0.04010014581190933	0.24701689820136147	0	0	4.128108672936259	13.277546806308951	CDH3;ICAM2;CDH15
Acute myeloid leukemia	2/67	0.04595976003474842	0.25157093012021353	0	0	6.102461538461538	18.795514699367523	BCL2A1;HRAS
Fc epsilon RI signaling pathway	2/68	0.04719864498475159	0.25157093012021353	0	0	6.00969696969697	18.349949199739168	FYN;HRAS
Renin secretion	2/69	0.04844971249705198	0.25157093012021353	0	0	5.919701492537313	17.9202912876736	EDN3;CLCA2
Central carbon metabolism in cancer	2/70	0.049712808802500015	0.25157093012021353	0	0	5.83235294117647	17.50576452422357	HRAS;GCK
Prolactin signaling pathway	2/70	0.049712808802500015	0.25157093012021353	0	0	5.83235294117647	17.50576452422357	HRAS;GCK
Melanoma	2/72	0.05227447898601839	0.25157093012021353	0	0	5.6651428571428575	16.719235864590853	EGF;HRAS
Non-small cell lung cancer	2/72	0.05227447898601839	0.25157093012021353	0	0	5.6651428571428575	16.719235864590853	EGF;HRAS
Glioma	2/75	0.056203426644554716	0.26060212968332025	0	0	5.431506849315069	15.636099989268667	EGF;HRAS
Gastric acid secretion	2/76	0.05753553512488888	0.26060212968332025	0	0	5.357837837837838	15.298515771440583	ATP4B;EZR
Axon guidance	3/182	0.06627409631709373	0.28471734054732534	0	0	3.3382427628237683	9.059844517256348	EFNB1;FYN;HRAS
ErbB signaling pathway	2/85	0.0700018390321402	0.28471734054732534	0	0	4.774698795180723	12.697040255712299	EGF;HRAS
Colorectal cancer	2/86	0.07143746073477412	0.28471734054732534	0	0	4.717619047619047	12.44948005343785	EGF;HRAS
Thiamine metabolism	1/15	0.07385304727236812	0.28471734054732534	0	0	14.062234794908063	36.6416559464346	ALPL
ECM-receptor interaction	2/88	0.07433735856064369	0.28471734054732534	0	0	4.607441860465117	11.975394023897678	GP6;GP5
Gap junction	2/88	0.07433735856064369	0.28471734054732534	0	0	4.607441860465117	11.975394023897678	EGF;HRAS
PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.07580136988597623	0.28471734054732534	0	0	4.554252873563218	11.74832793739907	EGF;HRAS
Phenylalanine metabolism	1/17	0.08328292883718645	0.2870641958847294	0	0	12.303217821782178	30.57979168054389	GOT1
Focal adhesion	3/201	0.08356968503730063	0.2870641958847294	0	0	3.014998469543924	7.483450649425726	EGF;FYN;HRAS
Prostate cancer	2/97	0.08783390418961914	0.2870641958847294	0	0	4.169052631578947	10.14041881906813	EGF;HRAS
Choline metabolism in cancer	2/98	0.08937613566563447	0.2870641958847294	0	0	4.125416666666666	9.962475190601934	EGF;HRAS
Rap1 signaling pathway	3/210	0.09237357343043388	0.2870641958847294	0	0	2.8825940565071	6.866092128459759	KITLG;EGF;HRAS
Glycosaminoglycan degradation	1/19	0.09261772960228992	0.2870641958847294	0	0	10.935093509350935	26.017591233462856	ARSB
Melanogenesis	2/101	0.09405077122227563	0.2870641958847294	0	0	3.9997979797979797	9.45520453285114	KITLG;HRAS
Neuroactive ligand-receptor interaction	4/341	0.09694494337693456	0.2870641958847294	0	0	2.369163689214558	5.5287089470148985	EDN3;CSH2;CSH1;F2
Protein digestion and absorption	2/103	0.09720595396627248	0.2870641958847294	0	0	3.92019801980198	9.137680962184412	CPA2;CELA3B
One carbon pool by folate	1/20	0.09724977164099889	0.2870641958847294	0	0	10.359041167274622	24.14146206514577	DHFR
cAMP signaling pathway	3/216	0.09844869237086458	0.2870641958847294	0	0	2.8005406174420258	6.492268587254964	EDN3;CNGA2;AMH
T cell receptor signaling pathway	2/104	0.09879482066162766	0.2870641958847294	0	0	3.88156862745098	8.984706098256526	FYN;HRAS
Arginine biosynthesis	1/22	0.10644372781945091	0.30356174229991556	0	0	9.371522866572372	20.9935120892893	GOT1
Renin-angiotensin system	1/23	0.11100587575178392	0.3108164521049949	0	0	8.945094509450945	19.66285757943244	ANPEP
Cholinergic synapse	2/113	0.11341238709229966	0.31180263292043386	0	0	3.5652252252252254	7.760513666329722	FYN;HRAS
Ras signaling pathway	3/232	0.11540746802899175	0.31180263292043386	0	0	2.602752414979489	5.620087404769793	KITLG;EGF;HRAS
Sphingolipid signaling pathway	2/119	0.12344888474568615	0.3251080672832642	0	0	3.381367521367521	7.0735777252077305	FYN;HRAS
Maturity onset diabetes of the young	1/26	0.12455438941371809	0.3251080672832642	0	0	7.87049504950495	16.39434189671731	GCK
Pathways in cancer	5/531	0.13517624089124078	0.34695235162085136	0	0	1.8983967700207753	3.7990257962126117	KITLG;EGF;F2;HRAS;CKS1B
Endocytosis	3/252	0.13802373454143704	0.3484533626128083	0	0	2.391262017768042	4.735487001012679	CYTH4;HRAS;ARFGAP1
FoxO signaling pathway	2/131	0.1441209130081196	0.35797775166532936	0	0	3.0649612403100774	5.937144565478081	EGF;HRAS
Autophagy	2/137	0.15471485015711253	0.36655518344915894	0	0	2.9278518518518517	5.463873778039772	ATG7;HRAS
Estrogen signaling pathway	2/137	0.15471485015711253	0.36655518344915894	0	0	2.9278518518518517	5.463873778039772	KRT19;HRAS
Insulin signaling pathway	2/137	0.15471485015711253	0.36655518344915894	0	0	2.9278518518518517	5.463873778039772	HRAS;GCK
Starch and sucrose metabolism	1/36	0.1682563218331979	0.3799108474528566	0	0	5.618953323903819	10.014473606609219	GCK
Tyrosine metabolism	1/36	0.1682563218331979	0.3799108474528566	0	0	5.618953323903819	10.014473606609219	GOT1
Alanine, aspartate and glutamate metabolism	1/37	0.1725058575997924	0.3799108474528566	0	0	5.462596259625963	9.599551979063234	GOT1
Thyroid cancer	1/37	0.1725058575997924	0.3799108474528566	0	0	5.462596259625963	9.599551979063234	HRAS
Breast cancer	2/147	0.17268674884220753	0.3799108474528566	0	0	2.724551724137931	4.785064875021463	EGF;HRAS
Gastric cancer	2/149	0.17632240422638285	0.3824457781811685	0	0	2.6872108843537417	4.663496260169139	EGF;HRAS
Ferroptosis	1/41	0.18929007620664925	0.39744810205553827	0	0	4.915346534653465	8.181469682114148	ATG7
MAPK signaling pathway	3/294	0.1897293171682093	0.39744810205553827	0	0	2.041757784025825	3.3937217257128602	KITLG;EGF;HRAS
Hepatitis C	2/157	0.19098155553318072	0.39744810205553827	0	0	2.547483870967742	4.217559330956843	EGF;HRAS
Hepatitis B	2/162	0.20022607993810035	0.41113088413956606	0	0	2.46725	3.968098285960021	CASP10;HRAS
Type II diabetes mellitus	1/46	0.20979699739375907	0.41684547938818295	0	0	4.368096809680968	6.821285040264925	GCK
Tight junction	2/169	0.2132552286636605	0.41684547938818295	0	0	2.3629940119760477	3.651453298209308	ARHGEF2;EZR
Nucleotide excision repair	1/47	0.21383631734848346	0.41684547938818295	0	0	4.27292294446836	6.591173482799382	CETN2
Other types of O-glycan biosynthesis	1/47	0.21383631734848346	0.41684547938818295	0	0	4.27292294446836	6.591173482799382	GALNT1
Arginine and proline metabolism	1/50	0.2258320069783284	0.43472661343328217	0	0	4.010709234188725	5.967790506031058	GOT1
Glycosaminoglycan biosynthesis	1/53	0.23764642747380324	0.45182160285142836	0	0	3.778750952018279	5.42995670098592	HS3ST5
Hedgehog signaling pathway	1/56	0.24928229119870132	0.45771505257631834	0	0	3.572097209720972	4.96224786993517	KIF3A
Pyrimidine metabolism	1/56	0.24928229119870132	0.45771505257631834	0	0	3.572097209720972	4.96224786993517	ENTPD6
Glutathione metabolism	1/57	0.25312169621510944	0.45771505257631834	0	0	3.508132956152758	4.81977087178201	ANPEP
Transcriptional misregulation in cancer	2/192	0.2565196635396153	0.45771505257631834	0	0	2.0745263157894738	2.8224966883661975	HPGD;BCL2A1
VEGF signaling pathway	1/59	0.2607422704872568	0.45771505257631834	0	0	3.3868214407647663	4.5526426981721455	HRAS
Notch signaling pathway	1/59	0.2607422704872568	0.45771505257631834	0	0	3.3868214407647663	4.5526426981721455	DTX3L
Viral myocarditis	1/60	0.264523634281119	0.45771505257631834	0	0	3.3292498741399563	4.427318638915545	FYN
Long-term depression	1/60	0.264523634281119	0.45771505257631834	0	0	3.3292498741399563	4.427318638915545	HRAS
GnRH secretion	1/64	0.27945851435839386	0.4756893047035024	0	0	3.1172402954581173	3.974174096178889	HRAS
Proteoglycans in cancer	2/205	0.28108913459752416	0.4756893047035024	0	0	1.9403940886699507	2.4625220340601093	EZR;HRAS
Glycolysis / Gluconeogenesis	1/67	0.290462233502279	0.4809804726811932	0	0	2.975097509750975	3.67805865550658	GCK
Long-term potentiation	1/67	0.290462233502279	0.4809804726811932	0	0	2.975097509750975	3.67805865550658	HRAS
Mitophagy	1/68	0.29409303370539047	0.4818119913896823	0	0	2.9305452933353036	3.5865745853618005	HRAS
Renal cell carcinoma	1/69	0.2977054357946365	0.4825961801302528	0	0	2.8873034362259755	3.498403379246233	HRAS
RIG-I-like receptor signaling pathway	1/70	0.3012995320852558	0.4833346660534312	0	0	2.8453149662792367	3.413383197114134	CASP10
Adherens junction	1/71	0.30487541445898425	0.4840290085225111	0	0	2.8045261669024044	3.331362193114698	FYN
Chronic myeloid leukemia	1/76	0.3224848002656778	0.5016430226354988	0	0	2.616897689768977	2.961541217779602	HRAS
Pancreatic cancer	1/76	0.3224848002656778	0.5016430226354988	0	0	2.616897689768977	2.961541217779602	EGF
B cell receptor signaling pathway	1/81	0.3396523554957474	0.5230646274634511	0	0	2.4527227722772276	2.6485301757911484	HRAS
Chemical carcinogenesis	2/239	0.3448552736943817	0.5258189321676711	0	0	1.65915611814346	1.7663881188757447	EGF;HRAS
Complement and coagulation cascades	1/85	0.3530756685001142	0.5298111507013872	0	0	2.3354549740688353	2.4313788515254124	F2
Insulin secretion	1/86	0.35638905886629263	0.5298111507013872	0	0	2.3078625509609783	2.381096298287925	GCK
Shigellosis	2/246	0.3577945433308069	0.5298111507013872	0	0	1.610983606557377	1.655763084642645	CYTH4;ARHGEF2
Salmonella infection	2/249	0.3633128605648063	0.5328588621617159	0	0	1.591174089068826	1.6110493508696981	CYTH4;HRAS
Small cell lung cancer	1/92	0.37591943748490464	0.5445996542434952	0	0	2.155042976825155	2.1084518539864536	CKS1B
GnRH signaling pathway	1/93	0.37911695126655665	0.5445996542434952	0	0	2.131510977184675	2.0673749692075583	HRAS
TGF-beta signaling pathway	1/94	0.3822982421487303	0.5445996542434952	0	0	2.1084850420525925	2.027422724538319	AMH
Staphylococcus aureus infection	1/95	0.38546339163987653	0.5445996542434952	0	0	2.0859490204339584	1.9885540869631606	KRT19
AGE-RAGE signaling pathway in diabetic complications	1/100	0.40104984239534247	0.5614697793534794	0	0	1.9800980098009802	1.8091552855878605	HRAS
Longevity regulating pathway	1/102	0.407174240334478	0.5631720342049531	0	0	1.9406920890108812	1.7437391595891547	HRAS
C-type lectin receptor signaling pathway	1/104	0.41323662250103704	0.5631720342049531	0	0	1.9028164952417572	1.6815853722527565	HRAS
NF-kappa B signaling pathway	1/104	0.41323662250103704	0.5631720342049531	0	0	1.9028164952417572	1.6815853722527565	BCL2A1
Glucagon signaling pathway	1/107	0.4222152748646144	0.5683732758224658	0	0	1.8486829815056978	1.5940083492830097	GCK
Drug metabolism	1/108	0.4251778207952197	0.5683732758224658	0	0	1.8313130378458407	1.5662264388401705	IMPDH2
HIF-1 signaling pathway	1/109	0.4281253246454937	0.5683732758224658	0	0	1.8142647598093142	1.539112117523574	EGF
TNF signaling pathway	1/112	0.4368783380844716	0.5728280363663335	0	0	1.764962982784765	1.4615667730033788	CASP10
Serotonergic synapse	1/113	0.43976642602899374	0.5728280363663335	0	0	1.749115983026874	1.4369189700230403	HRAS
Leukocyte transendothelial migration	1/114	0.44263984628307584	0.5728280363663335	0	0	1.7335494611408044	1.4128407785296562	EZR
Neurotrophin signaling pathway	1/119	0.4567895003338674	0.5862131920951299	0	0	1.6596744420204732	1.300409040938608	HRAS
Thyroid hormone signaling pathway	1/121	0.46234924133329824	0.5884444889696523	0	0	1.6318481848184818	1.2588643799341437	HRAS
MicroRNAs in cancer	2/310	0.47085921974690387	0.594363277385436	0	0	1.2720779220779221	0.9581241630669427	EZR;HRAS
Osteoclast differentiation	1/127	0.4786926108283515	0.5963253493435982	0	0	1.5536696526795537	1.1445831795753345	FYN
Lysosome	1/128	0.4813682629881532	0.5963253493435982	0	0	1.5413580728151555	1.1269218485744383	ARSB
Relaxin signaling pathway	1/129	0.4840303160256479	0.5963253493435982	0	0	1.5292388613861385	1.1096275507822333	HRAS
Vascular smooth muscle contraction	1/133	0.49454390098005757	0.599683155519125	0	0	1.4825982598259826	1.043926127965857	EDN3
Oxidative phosphorylation	1/133	0.49454390098005757	0.599683155519125	0	0	1.4825982598259826	1.043926127965857	ATP4B
Apelin signaling pathway	1/137	0.5048453145340125	0.6024041406768853	0	0	1.4387012230634828	0.9833568962561355	HRAS
Human papillomavirus infection	2/331	0.5053816014325154	0.6024041406768853	0	0	1.1896048632218845	0.8118357137775956	EGF;HRAS
Fluid shear stress and atherosclerosis	1/139	0.5099177854032545	0.6024041406768853	0	0	1.4177069880901134	0.9548338385624286	ARHGEF2
Ubiquitin mediated proteolysis	1/140	0.5124346910952726	0.6024041406768853	0	0	1.407436427095947	0.9409866726994145	HERC4
Signaling pathways regulating pluripotency of stem cells	1/143	0.5199088659087284	0.6065603435601832	0	0	1.3774926788453494	0.9010203589432639	HRAS
mTOR signaling pathway	1/154	0.5463562659117879	0.6279019772419054	0	0	1.2777454216009836	0.7723766817717403	HRAS
Oxytocin signaling pathway	1/154	0.5463562659117879	0.6279019772419054	0	0	1.2777454216009836	0.7723766817717403	HRAS
Cellular senescence	1/156	0.551007458939614	0.6285566568644486	0	0	1.2611306291919515	0.7516425981968115	HRAS
Hippo signaling pathway	1/163	0.5669178348455791	0.6419510776927881	0	0	1.2062095098398729	0.6845732282025914	AMH
Hepatocellular carcinoma	1/168	0.5779393269282427	0.6496544258901413	0	0	1.1697990158297267	0.641384875357916	HRAS
Tuberculosis	1/180	0.6032706296625326	0.6732150504929713	0	0	1.0907129819127164	0.5512347549900032	CASP10
Alcoholism	1/186	0.6153657361992282	0.6817721106092168	0	0	1.055017393631255	0.5122515574271667	HRAS
Neutrophil extracellular trap formation	1/189	0.6212756340475746	0.6821721112470644	0	0	1.0380240151674742	0.4940791278583512	ATG7
Chemokine signaling pathway	1/192	0.6270956027529703	0.6821721112470644	0	0	1.0215644601109326	0.47671946408780363	HRAS
Kaposi sarcoma-associated herpesvirus infection	1/193	0.6290158428382022	0.6821721112470644	0	0	1.0161922442244224	0.4711055408193936	HRAS
Viral carcinogenesis	1/203	0.647687775857469	0.6975099124618896	0	0	0.9653955494559356	0.4193162032440959	HRAS
Human immunodeficiency virus 1 infection	1/212	0.6636951598239673	0.7097851014784095	0	0	0.9237952231242081	0.378693529711757	HRAS
Lipid and atherosclerosis	1/215	0.6688692284260657	0.710385249500787	0	0	0.9107060238734154	0.3662556464602094	HRAS
Human T-cell leukemia virus 1 infection	1/219	0.675645560072286	0.7126672345967948	0	0	0.8938141520574076	0.3504526054178974	HRAS
Human cytomegalovirus infection	1/225	0.685553406418609	0.7181988067242571	0	0	0.8696074964639321	0.32830193922943623	HRAS
Thermogenesis	1/232	0.6967343153054589	0.7201146614566488	0	0	0.842955724143843	0.30460299848282196	HRAS
Coronavirus disease	1/232	0.6967343153054589	0.7201146614566488	0	0	0.842955724143843	0.30460299848282196	F2
Calcium signaling pathway	1/240	0.7090310917935283	0.727938587574689	0	0	0.8144082190645843	0.2800390714500137	EGF
Prion disease	1/273	0.7547462850179063	0.7697412443228979	0	0	0.7144001164822364	0.2010133558639159	FYN
Alzheimer disease	1/369	0.8510770684266656	0.8622754509059638	0	0	0.5254520017219113	0.08473049741517083	HRAS
Olfactory transduction	1/440	0.8971878488350997	0.903051821703303	0	0	0.43886871602877825	0.04761287571668549	CNGA2
Pathways of neurodegeneration	1/475	0.9143940539397574	0.9143940539397574	0	0	0.4057317124117475	0.036310419659895427	HRAS
